Risk of Anemia and Effects of Oral Iron Therapy in Non-Anemic Iron-Deficient Women (18-55 Years)
Recruiting
N/A
Interventional Study
Non-Anemic Iron Deficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 55
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Istanbul University - Cerrahpasa · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study investigates the risk of anemia development in women aged 18-55 years with non-anemic iron deficiency and evaluates the clinical effects of oral iron therapy. The study consists of a two-month nutritional intervention phase followed by a one-month oral iron treatment phase. Participants first receive dietary counseling aimed at increasing iron intake and absorption. After two months, ch…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female participants aged 18-55 years (including premenopausal and menopausal women).
* Normal hemoglobin level (≥ 12 g/dL).
* Serum ferritin \< 15 μg/L (WHO criteria for iron deficiency).
* Mentzer index \> 13.
* Normal levels of vitamin B12, folic acid, thyroid hormones (TSH …
Contacts